Effects of insulin-like growth factor 1 in preventing acute coronary syndromes: The PRIME study-Reference-Cited by-同舟云学术

Effects of insulin-like growth factor 1 in preventing acute coronary syndromes: The PRIME study

Published:2011-10 Issue:2 Volume:218 Page:464-469
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Ruidavets J.B.,Luc G.,Machez E.,Genoux A.L.,Kee F.,Arveiler D.,Morange P.,Woodside J.V.,Amouyel P.,Evans A.,Ducimetière P.,Bingham A.,Ferrières J.,Perret B.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Serum total IGF-I, free IGF-I and IGFBP-1 levels in an elderly population. Relation to cardiovascular risk factors and disease;Janssen;Arterioscler Thromb Vasc Biol,1998

2. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations;Friedrich;J Clin Endocrinol Metab,2009

3. Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients;Schneider;Eur J Endocrinol,2008

4. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study;Hunt;Ann Epidemiol,2006

5. The association of serum Insulin-like growth factor-I with mortality, cardiovascular disease and cancer in the elderly: a population-based study;Van Bunderen;J Clin Endocrinol Metab,2010

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factores asociados a infarto agudo del miocardio en usuarios de un programa de rehabilitación cardiovascular;Revista Med;2024-04-10

2. Upregulation of Anti-Angiogenic miR-106b-3p Correlates Negatively with IGF-1 and Vascular Health Parameters in a Model of Subclinical Cardiovascular Disease: Study with Metformin Therapy;Biomedicines;2024-01-12

3. Challenges in the care of individuals with severe primary insulin-like growth factor-I deficiency (SPIGFD): an international, multi-stakeholder perspective;Orphanet Journal of Rare Diseases;2023-10-07

4. Circulating IGF-1 and IGFBP-2 may be biomarkers for risk stratification in patients with acute coronary syndrome: A prospective cohort study;Nutrition, Metabolism and Cardiovascular Diseases;2023-09

5. The role of IGF-1/GH in the aging process and the development of age-related diseases;Obesity and metabolism;2023-06-06